Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  rociletinib
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CO-1686-032, NCI-2016-00360, NCT02630186
Genetic Changes before and after Treatment with EGFR-Inhibitor CO-1686 in Patients with Stage IIIB-IV Non-small Cell Lung Cancer with EGFR Mutation
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201604010, NCI-2016-00550, NCT02705339
Start Over